Ovarian hyperstimulation syndrome. Hyperstimulation of ovaries
Conditions
Interventions
Intervention 1: Intervention group: drug(cetrotide) for 3 days. Intervention 2: Intervention group:drug(cetrotide) for 7 days.
Sponsors
Birjand University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Having informed consent to enter the study. The possibility of useful intervention on individuals. Age between 18 and 40 years. The person is at risk for OHSS syndrome (for example, the number of recovered eggs is more than 15 or serum estradiol more than 3000 pg / ml Any person who does not meet any of the exclusion criteria will be included in the study if satisfied
Exclusion criteria
Exclusion criteria: Dissatisfaction to enter the study Age less than 18 years or more than 40 years Any disease that interferes with the intended intervention. Patient with diabetes / hemophilia or coagulation disorde Patients with pulmonary fibrosis, swelling or inflammation around the heart or lungs, high blood pressure, liver disease, heart valve disease, or allergy to cabergoline or ergot derivatives Use of drugs that affect the development of OHSS syndrome (calcium gluconate / metformin / letrozole / other GNRH-ant antagonists) Pregnancy during the study cycle Contraindications that are considered by a specialist and are not included in the test.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ovarian hyperstimulation syndrome. Timepoint: One week after OPU. Method of measurement: Clinical and laboratory evaluation and sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactvajihe hazari
Birjand University of Medical Sciences
Outcome results
None listed